Detalles de la búsqueda
1.
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial.
Lancet
; 401(10394): 2124-2137, 2023 06 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37302395
2.
Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis.
Breast Cancer Res Treat
; 197(2): 405-416, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36396774
3.
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
Lancet
; 395(10237): 1613-1626, 2020 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32580883
4.
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.
Lancet
; 390(10099): 1048-1060, 2017 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28779963
5.
Breast cancer radiation therapy - Authors' reply.
Lancet
; 396(10262): 1559-1560, 2020 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33189173
6.
Targeted radiotherapy for early breast cancer - Authors' reply.
Lancet
; 391(10115): 27-28, 2018 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29323651
7.
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.
Lancet Oncol
; 14(11): 1086-1094, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24055415
8.
One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
Health Technol Assess
; 27(25): 1-176, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37991196
9.
Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials.
Lancet Oncol
; 11(3): 231-40, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20138809
10.
TP53 modulates radiotherapy fraction size sensitivity in normal and malignant cells.
Sci Rep
; 11(1): 7119, 2021 03 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-33782505
11.
Late effects of breast radiotherapy.
Lancet
; 383(9926): 1383-4, 2014 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-24759249
12.
Genome-wide transcriptomic profiling of microdissected human breast tissue reveals differential expression of KIT (c-Kit, CD117) and oestrogen receptor-alpha (ERalpha) in response to therapeutic radiation.
J Pathol
; 219(1): 131-40, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19562735
13.
Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer.
J Clin Oncol
; 38(28): 3261-3272, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32663119
14.
Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld?
Radiother Oncol
; 90(1): 14-22, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18502528
15.
Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial.
Radiother Oncol
; 134: 220-230, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31005219
16.
Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial.
J Clin Oncol
; 37(4): 305-317, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30532984
17.
Hypofractionated radiotherapy for breast cancer.
N Engl J Med
; 362(19): 1843; author reply 1843-4, 2010 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-20463347
18.
Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials.
Radiother Oncol
; 126(1): 155-162, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29153463
19.
Prolongation of overall treatment time as a cause of treatment failure in early breast cancer: An analysis of the UK START (Standardisation of Breast Radiotherapy) trials of radiotherapy fractionation.
Radiother Oncol
; 121(3): 420-423, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27666929
20.
Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.
Radiother Oncol
; 121(3): 431-439, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27443449